Why the study?
Does five doses of trivalent oral polio vaccine improve seroconversion rates in infants in the tropics compared to two or three doses?
Does five doses of trivalent oral polio vaccine improve seroconversion rates in infants in the tropics compared to two or three doses?
Administering five doses of oral polio vaccine to infants in the tropics achieves high seroconversion rates, overcoming factors like enterovirus interference and malnutrition.
Answers are grounded in this paper and cite their sources.
Five-dose OPV may boost seroconversion in tropical infants; leaves open optimal schedules pending RCTs.
Sixty-two infants 1-12 months of age were administered five doses of trivalent oral polio vaccine (TOPV) at intervals of 4 weeks. The seroconversion achieved were 88.7, 93.5 and 96.5 per cent for type I, II, and III polioviruses. These seroconversion rates are significantly better when compared to seroconversion achieved after two and three doses of trivalent oral polio vaccine. Factors which were considered in previous studies to be responsible for low seroconversion rates viz. interference by enteroviruses, breast feeding, malnutrition, and age were found to be insignificant when five doses of oral polio vaccine were given. It is possible that these effects were overcome by increasing the number of doses of trivalent oral polio vaccine.
No takes yet. Share an insight, caveat, or question.
Chopra et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: